Literature DB >> 17099145

The pathology of devil facial tumor disease (DFTD) in Tasmanian Devils (Sarcophilus harrisii).

R Loh1, J Bergfeld, D Hayes, A O'hara, S Pyecroft, S Raidal, R Sharpe.   

Abstract

A disfiguring and debilitating neoplastic condition known as devil facial tumor disease (DFTD) has been discovered in wild Tasmanian Devils (Sarcophilus harrisii) across 51% of its natural range, with population declines of up to 80% in some areas (C. Hawkins, personal communication). Between 2001 and 2004, 91 cases were examined. The tumors presented as large, solid, soft tissue masses usually with flattened, centrally ulcerated, and exudative surfaces. They were typically multicentric, appearing first in the oral, face, or neck regions. Histologically, the tumors were composed of circumscribed to infiltrative nodular aggregates of round to spindle-shaped cells, often within a pseudocapsule and divided into lobules by delicate fibrous septae. They were locally aggressive and metastasized in 65% of cases. There was minimal cytologic differentiation among the tumor cell population under light and electron microscopic examination. The results indicate DFTD to be an undifferentiated soft tissue neoplasm.

Entities:  

Mesh:

Year:  2006        PMID: 17099145     DOI: 10.1354/vp.43-6-890

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  52 in total

Review 1.  Dental Pulp Stem Cells - Exploration in a Novel Animal Model: the Tasmanian Devil (Sarcophilus harrisii).

Authors:  Chelsea M Graham; Karlea L Kremer; Simon A Koblar; Monica A Hamilton-Bruce; Stephen B Pyecroft
Journal:  Stem Cell Rev Rep       Date:  2018-08       Impact factor: 5.739

2.  MHC gene copy number variation in Tasmanian devils: implications for the spread of a contagious cancer.

Authors:  Hannah V Siddle; Jolanta Marzec; Yuanyuan Cheng; Menna Jones; Katherine Belov
Journal:  Proc Biol Sci       Date:  2010-03-10       Impact factor: 5.349

3.  Sex bias in ability to cope with cancer: Tasmanian devils and facial tumour disease.

Authors:  Manuel Ruiz-Aravena; Menna E Jones; Scott Carver; Sergio Estay; Camila Espejo; Andrew Storfer; Rodrigo K Hamede
Journal:  Proc Biol Sci       Date:  2018-11-21       Impact factor: 5.349

4.  Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.

Authors:  Gabriella K Brown; Cesar Tovar; Anne A Cooray; Alexandre Kreiss; Jocelyn Darby; James M Murphy; Lynn M Corcoran; Silvana S Bettiol; A Bruce Lyons; Gregory M Woods
Journal:  Immunol Cell Biol       Date:  2016-04-19       Impact factor: 5.126

5.  A second transmissible cancer in Tasmanian devils.

Authors:  Ruth J Pye; David Pemberton; Cesar Tovar; Jose M C Tubio; Karen A Dun; Samantha Fox; Jocelyn Darby; Dane Hayes; Graeme W Knowles; Alexandre Kreiss; Hannah V T Siddle; Kate Swift; A Bruce Lyons; Elizabeth P Murchison; Gregory M Woods
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

Review 6.  Transmissible Tumors: Breaking the Cancer Paradigm.

Authors:  Elaine A Ostrander; Brian W Davis; Gary K Ostrander
Journal:  Trends Genet       Date:  2015-12-11       Impact factor: 11.639

Review 7.  The role of the Major Histocompatibility Complex in the spread of contagious cancers.

Authors:  Katherine Belov
Journal:  Mamm Genome       Date:  2010-10-21       Impact factor: 2.957

8.  Disease and the dynamics of extinction.

Authors:  Hamish McCallum
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-10-19       Impact factor: 6.237

9.  Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial.

Authors:  Hannah V Siddle; Alexandre Kreiss; Mark D B Eldridge; Erin Noonan; Candice J Clarke; Stephen Pyecroft; Gregory M Woods; Katherine Belov
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

10.  Common avian infection plagued the tyrant dinosaurs.

Authors:  Ewan D S Wolff; Steven W Salisbury; John R Horner; David J Varricchio
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.